MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,344,510 | +9.3% | 134,451 | +35.9% | 0.17% | +0.6% |
| Q2 2023 | $1,230,160 | -18.0% | 98,967 | -7.6% | 0.17% | -16.7% |
| Q1 2023 | $1,500,611 | +139.7% | 107,110 | +386.2% | 0.20% | +269.1% |
| Q2 2022 | $626,000 | +57.7% | 22,029 | +95.5% | 0.06% | +61.8% |
| Q1 2022 | $397,000 | -28.7% | 11,267 | -15.3% | 0.03% | -19.0% |
| Q4 2021 | $557,000 | -45.7% | 13,302 | -36.4% | 0.04% | -43.2% |
| Q3 2021 | $1,026,000 | +46.4% | 20,899 | +24.4% | 0.07% | +60.9% |
| Q2 2021 | $701,000 | – | 16,799 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |